REGENEREX PHARMA, INC. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Regenerex Pharma, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q2 2010 to Q3 2024.
  • Regenerex Pharma, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$6.42M, a 26.9% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$6.42M -$1.36M -26.9% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$5.89M -$3.63M -161% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$5.62M -$3.54M -171% Mar 31, 2024 10-Q 2024-11-04
Q4 2023 -$5.32M -$3.3M -163% Dec 31, 2023 10-Q 2024-02-05
Q3 2023 -$5.06M -$3.08M -156% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$2.26M -$300K -15.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$2.07M -$137K -7.1% Mar 31, 2023 10-K 2024-06-24
Q4 2022 -$2.03M -$139K -7.4% Dec 31, 2022 10-Q 2023-01-24
Q3 2022 -$1.98M -$170K -9.38% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$1.96M -$185K -10.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$1.93M -$196K -11.2% Mar 31, 2022 10-K 2023-06-09
Q4 2021 -$1.89M -$432K -29.7% Dec 31, 2021 10-Q/A 2022-02-03
Q3 2021 -$1.81M -$386K -27.2% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 -$1.77M -$378K -27.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$1.74M -$354K -25.5% Mar 31, 2021 10-Q/A 2022-02-03
Q4 2020 -$1.45M -$110K -8.15% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 -$1.42M -$96.4K -7.28% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 -$1.4M -$89.1K -6.83% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 -$1.39M -$112K -8.76% Mar 31, 2020 10-K 2021-06-23
Q4 2019 -$1.35M -$87.7K -6.98% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 -$1.32M -$121K -10% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 -$1.31M -$107K -8.95% Jun 30, 2019 10-Q/A 2019-07-29
Q1 2019 -$1.27M -$93.6K -7.93% Mar 31, 2019 10-K/A 2020-08-11
Q4 2018 -$1.26M -$91.1K -7.81% Dec 31, 2018 10-Q 2019-02-04
Q3 2018 -$1.2M -$47.8K -4.14% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 -$1.2M -$51.1K -4.46% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$1.18M -$49.7K -4.39% Mar 31, 2018 10-K 2019-06-24
Q4 2017 -$1.17M Dec 31, 2017 10-Q 2018-02-08
Q3 2017 -$1.16M Sep 30, 2017 10-Q 2017-11-07
Q2 2017 -$1.15M Jun 30, 2017 10-Q 2017-08-07
Q1 2017 -$1.13M Mar 31, 2017 10-K 2018-06-21
Q4 2014 -$106K $0 0% Nov 30, 2014 10-K 2015-03-03
Q3 2014 -$106K Aug 31, 2014 10-Q 2014-10-20
Q2 2014 -$106K May 31, 2014 10-Q/A 2014-07-23
Q1 2014 -$106K Feb 28, 2014 10-Q 2014-04-11
Q4 2013 -$106K $0 0% Nov 30, 2013 10-K 2015-03-03
Q4 2012 -$106K $0 0% Nov 30, 2012 10-K 2014-02-28
Q3 2012 -$106K $0 0% Aug 31, 2012 10-Q 2012-10-15
Q2 2012 -$106K May 31, 2012 10-Q 2012-07-16
Q4 2011 -$106K $0 0% Nov 30, 2011 10-K/A 2013-02-28
Q3 2011 -$106K Aug 31, 2011 10-Q 2011-10-13
Q4 2010 -$106K Nov 30, 2010 10-K 2012-02-28
Q2 2010 $104K May 20, 2010 10-K 2015-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.